Leukocytic-vascular endothelial growth factor and integrin alphavbeta3 in acute myeloid leukemia: relation to clinical outcome.
Abou-Shamaa
Lobna A
LA
Department of Immunology, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Mahmoud
Gihan N
GN
D000328:Adult; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000097:blood*; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000473:pathology; D007962:Leukocytes / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D014407:Tumor Cells, Cultured; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
D039302:Integrin alphaVbeta3; D042461:Vascular Endothelial Growth Factor A